Serum procalcitonin as a biomarker of bloodstream infection & focal bacterial infection in febrile patients.
Acute fever
bacteraemia
biomarker
focal bacterial infection
mortality
serum procalcitonin
Journal
The Indian journal of medical research
ISSN: 0971-5916
Titre abrégé: Indian J Med Res
Pays: India
ID NLM: 0374701
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
entrez:
29
5
2020
pubmed:
29
5
2020
medline:
28
4
2021
Statut:
ppublish
Résumé
Bacteraemia is a serious form of infection in patients presenting with fever, thus, there is a necessity for a biomarker for rapid diagnosis of bacteraemia in such patients to make better therapeutic decisions. This study was conducted to measure the serum procalcitonin (PCT) levels at the time of initial presentation as a biomarker for identifying bacteraemia and as a predictor of mortality in patients admitted with acute fever. Four hundred and eighty patients, who presented with acute fever requiring admission to a tertiary care teaching hospital in south India, were prospectively studied. All patients were evaluated with a detailed history, physical examination, laboratory and imaging studies. Baseline serum PCT was measured for each patient within six hours of admission. Among patients with single infectious cause (n=275), significantly higher median serum PCT levels were evident in bacteraemia compared to leptospirosis (P=0.002), dengue (P <0.001), scrub typhus (P <0.001) and evident focus of infection without bacteraemia (P=0.036). By receiver-operator characteristic curve analysis, at a cut-off value of >3.2 ng/ml, the sensitivity and specificity of serum PCT levels in predicting bacteraemia were 81.1 and 63.3 per cent, respectively. As per the worst-case scenario analysis, 91 (18.9%) patients had a poor outcome and these had significantly higher median serum PCT levels compared to survivors (n=389) [9.46 (2.03-44.4) vs. 1.23 (0.34-7.645); P <0.001]. At a cut-off value of >3.74 ng/ml, serum PCT levels at initial presentation predicted in-hospital mortality with a sensitivity and specificity of 67 and 67.5 per cent, respectively. Our observations suggest that serum PCT level may be a useful biomarker for identifying bacteraemia as well as predicting mortality in patients with acute fever requiring admission to hospital.
Sections du résumé
Background & objectives
Bacteraemia is a serious form of infection in patients presenting with fever, thus, there is a necessity for a biomarker for rapid diagnosis of bacteraemia in such patients to make better therapeutic decisions. This study was conducted to measure the serum procalcitonin (PCT) levels at the time of initial presentation as a biomarker for identifying bacteraemia and as a predictor of mortality in patients admitted with acute fever.
Methods
Four hundred and eighty patients, who presented with acute fever requiring admission to a tertiary care teaching hospital in south India, were prospectively studied. All patients were evaluated with a detailed history, physical examination, laboratory and imaging studies. Baseline serum PCT was measured for each patient within six hours of admission.
Results
Among patients with single infectious cause (n=275), significantly higher median serum PCT levels were evident in bacteraemia compared to leptospirosis (P=0.002), dengue (P <0.001), scrub typhus (P <0.001) and evident focus of infection without bacteraemia (P=0.036). By receiver-operator characteristic curve analysis, at a cut-off value of >3.2 ng/ml, the sensitivity and specificity of serum PCT levels in predicting bacteraemia were 81.1 and 63.3 per cent, respectively. As per the worst-case scenario analysis, 91 (18.9%) patients had a poor outcome and these had significantly higher median serum PCT levels compared to survivors (n=389) [9.46 (2.03-44.4) vs. 1.23 (0.34-7.645); P <0.001]. At a cut-off value of >3.74 ng/ml, serum PCT levels at initial presentation predicted in-hospital mortality with a sensitivity and specificity of 67 and 67.5 per cent, respectively.
Interpretation & conclusions
Our observations suggest that serum PCT level may be a useful biomarker for identifying bacteraemia as well as predicting mortality in patients with acute fever requiring admission to hospital.
Identifiants
pubmed: 32461398
pii: IndianJMedRes_2020_151_4_342_284214
doi: 10.4103/ijmr.IJMR_324_18
pmc: PMC7371069
doi:
Substances chimiques
Biomarkers
0
Procalcitonin
0
Calcitonin
9007-12-9
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
342-349Déclaration de conflit d'intérêts
None
Références
J Crit Care. 2015 Feb;30(1):218.e7-12
pubmed: 25263339
Clin Microbiol Infect. 2015 Apr;21(4):313-22
pubmed: 25753137
Actas Urol Esp. 2015 Oct;39(8):502-10
pubmed: 25944771
Indian J Med Res. 2015 Mar;141(3):271-3
pubmed: 25963487
Indian J Med Res. 2016 Jun;143(6):793-797
pubmed: 27748304
Diagn Microbiol Infect Dis. 2004 Aug;49(4):237-41
pubmed: 15313527
Crit Care. 2008;12(3):211
pubmed: 18466649
Am J Med Sci. 2015 Jun;349(6):499-504
pubmed: 25992537
Ann Intensive Care. 2012 Jul 23;2(1):32
pubmed: 22824162
ScientificWorldJournal. 2010 Oct 01;10:1941-6
pubmed: 20890583
J Antimicrob Chemother. 2011 Apr;66 Suppl 2:ii33-40
pubmed: 21398306
Clin Chem Lab Med. 2014 Oct;52(10):1465-72
pubmed: 24803611
Clin Microbiol Infect. 2015 May;21(5):474-81
pubmed: 25726038
Crit Care. 2010;14(6):R206
pubmed: 21083886
Clin Infect Dis. 1999 Aug;29(2):398-407
pubmed: 10476749
J Infect Dis. 2001 Oct 15;184(8):1091-2
pubmed: 11574929
Shock. 2009 Jun;31(6):586-91
pubmed: 19060784
Yonsei Med J. 2011 Mar;52(2):276-81
pubmed: 21319346
J Clin Endocrinol Metab. 2001 Jan;86(1):396-404
pubmed: 11232031
Indian J Med Res. 2015 Mar;141(3):315-21
pubmed: 25963492
Clin Infect Dis. 2002 Jul 15;35(2):156-61
pubmed: 12087521
BMC Infect Dis. 2008 Mar 26;8:38
pubmed: 18366777
Radiology. 1982 Apr;143(1):29-36
pubmed: 7063747
Crit Care Med. 2006 Oct;34(10):2596-602
pubmed: 16915118
Crit Care. 2016 Sep 01;20:247
pubmed: 27581757
Clin Infect Dis. 2001 Jun 15;32(12):1718-25
pubmed: 11360214
BMC Res Notes. 2014 Jul 17;7:458
pubmed: 25034373
N Engl J Med. 2018 Jul 19;379(3):236-249
pubmed: 29781385